Dakota Wealth Management Decreases Stake in Cencora, Inc. $COR

Dakota Wealth Management lowered its stake in Cencora, Inc. (NYSE:COR) by 4.7% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 35,997 shares of the company’s stock after selling 1,759 shares during the period. Dakota Wealth Management’s holdings in Cencora were worth $11,250,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Cloud Capital Management LLC purchased a new position in shares of Cencora in the third quarter worth $31,000. Vermillion & White Wealth Management Group LLC grew its holdings in Cencora by 69.4% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock worth $31,000 after acquiring an additional 43 shares during the last quarter. Westside Investment Management Inc. increased its position in shares of Cencora by 200.0% in the third quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after acquiring an additional 70 shares during the period. Copia Wealth Management increased its position in shares of Cencora by 505.0% in the third quarter. Copia Wealth Management now owns 121 shares of the company’s stock valued at $38,000 after acquiring an additional 101 shares during the period. Finally, Caldwell Trust Co bought a new position in shares of Cencora during the second quarter valued at about $46,000. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Insider Buying and Selling at Cencora

In related news, EVP Silvana Battaglia sold 1,677 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $345.00, for a total value of $578,565.00. Following the sale, the executive vice president owned 18,796 shares in the company, valued at $6,484,620. This represents a 8.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Robert P. Mauch sold 5,096 shares of the firm’s stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total value of $1,807,704.08. Following the transaction, the chief executive officer directly owned 66,726 shares of the company’s stock, valued at approximately $23,669,713.98. This trade represents a 7.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 15,220 shares of company stock valued at $5,282,867. Corporate insiders own 0.38% of the company’s stock.

Cencora Stock Up 1.4%

Shares of NYSE:COR opened at $365.97 on Tuesday. The firm has a market capitalization of $71.19 billion, a P/E ratio of 43.99, a P/E/G ratio of 1.68 and a beta of 0.68. The company has a debt-to-equity ratio of 3.62, a quick ratio of 0.51 and a current ratio of 0.92. The stock has a 50 day moving average price of $349.72 and a 200-day moving average price of $332.01. Cencora, Inc. has a 52-week low of $241.48 and a 52-week high of $377.54.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating the consensus estimate of $4.04 by $0.04. The company had revenue of $85.93 billion for the quarter, compared to analyst estimates of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The firm’s revenue was up 5.5% on a year-over-year basis. During the same period in the previous year, the company posted $3.73 earnings per share. As a group, equities research analysts anticipate that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Friday, February 13th. Cencora’s dividend payout ratio is 28.85%.

Analysts Set New Price Targets

COR has been the topic of several recent analyst reports. Barclays raised their target price on Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a research note on Friday, February 13th. Bank of America dropped their price objective on Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a report on Monday, January 5th. Wells Fargo & Company boosted their target price on Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. UBS Group upped their target price on Cencora from $380.00 to $415.00 and gave the company a “buy” rating in a report on Friday, November 7th. Finally, TD Cowen lifted their price target on shares of Cencora from $350.00 to $400.00 and gave the company a “buy” rating in a report on Monday, November 10th. Eleven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $399.00.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.